Skip to content

A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents

Comparison of Rates of Strut Malapposition Between Everolimus and Sirolimus Eluting Stents - A Randomised Optical Coherence Tomography Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01201369
Acronym
ORCA-2
Enrollment
40
Registered
2010-09-14
Start date
2010-09-30
Completion date
2011-07-31
Last updated
2011-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Percutaneous Coronary Intervention, Coronary Artery Stenosis, Acute Myocardial Infarction, Coronary Artery Stent, Optical Coherence Tomography

Brief summary

Despite recent advances in stent technology and clot reducing drug therapy, acute stent occlusion or thrombosis (ST), still occurs and can be life threatening. It has been shown that certain features of how the stent relates to the artery wall may predict ST. One such feature, so-called stent strut malapposition (SSM), can be assessed after implantation but current imaging techniques are relatively unreliable. Optical Coherence Tomography (OCT) is a newer technology that can be performed safely and easily after angioplasty and may allow the stent struts to be assessed more accurately and reliably. This study will use OCT to examine how two different types of commonly used drug-eluting stents relate to the artery wall. The Xience V (Abbott Vascular, USA) stent has thinner struts and a more open frame than the Cypher (Cordis, USA) stent. We hypothesise therefore that the potentially more pliable structure of the Xience V stent will be associated with greater contact with the vessel wall. This may have a bearing on the relative rate of SSM, although large studies have shown the rate to be low in both the Cypher and the Xience V stent. We believe that OCT imaging of SSM and symmetry of the stent immediately after angioplasty will compliment conventional visual assessment and may identify those patients in whom further improvement of stent with a balloon is necessary. This study will involve the random allocation of forty patients requiring coronary angioplasty to one of the Cypher or Xience V stent. The procedure will be performed in the usual manner as indicated clinically and will include imaging of the stented artery segment with OCT once the operator is satisfied with the visual result by angiography.

Interventions

DEVICECoronary Stent Cypher

The angioplasty will then be performed in a usual fashion in accordance with the operator's discretion and local protocols.

DEVICECoronary stent Xience

The angioplasty will then be performed in a usual fashion in accordance with the operator's discretion and local protocols

Sponsors

Royal Brompton & Harefield NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Presence of a coronary artery stenosis undergoing percutaneous coronary intervention and stenting (PCI). * Eligibility for drug eluting stent (DES) deployment. * Stable or unstable coronary syndrome presentation, including ST elevation myocardial infarction (STEMI). * Aged 18-90

Exclusion criteria

* Contraindication to the use of a DES. * Target lesion located within previous stent (in stent restenosis). * Sustained haemodynamic instability following stent deployment (Systolic BP 90≤ mmHg or sustained ventricular arrhythmia).

Design outcomes

Primary

MeasureTime frameDescription
Stent strut malapposition (SSM)Immediate post stent deployment during the same angiographic procedure within 60 minutesSSM will be quoted as the percentage of malapposed stent struts as a proportion of the total number of struts analysed within each stent group.

Secondary

MeasureTime frameDescription
Stent eccentricity index (SEI)Immediate post stent deployment during the same angiographic procedure within 60 minutesThis is a commonly used measure that is designed to quantify the uniformity and symmetry of the stent after it has been deployed in the coronary artery. It is calculated as the minimum diameter of the stent divided by the maximum diameter of the stent at a preset point. The mean SEI will be compared between two stent type groups.
Degree of stent embeddingImmediate post stent deployment during the same angiographic procedure within 60 minutesThis relates to what degree, if at all, the stent strut is 'buried' within the coronary artery wall. The proportion of each strut that is buried or embedded will be calculated and then averaged for each stent group. A strut that is buried in the vessel wall for more than half its thickness will be defined as 'embedded'.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026